Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis

Is There an Association Between Clinical Presentation and the Location and Extent of Myocardial Involvement of Cardiac Sarcoidosis as Assessed by 18 F- Fluorodoexyglucose Positron Emission Tomography?

(2013) Brian A. Mc Ardle et al.   Circulation-Cardiovascular Imaging

Cardiac Positron Emission Tomography Enhances Prognostic Assessments of Patients With Suspected Cardiac Sarcoidosis

(2013) Ron Blankstein et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

CMR Imaging Predicts Death and Other Adverse Events in Suspected Cardiac Sarcoidosis

(2013) Simon Greulich et al.   JACC-Cardiovascular Imaging

Intra-reader reliability of FDG PET volumetric tumor parameters: effects of primary tumor size and segmentation methods

(2012) B. Shah et al.   ANNALS OF NUCLEAR MEDICINE

Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators

(2012) Brian P. Betensky et al.   HEART RHYTHM

Heterogeneous Myocardial FDG Uptake and the Disease Activity in Cardiac Sarcoidosis

(2010) Nobuhiro Tahara et al.   JACC-Cardiovascular Imaging

Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis

(2009) Rumman Langah et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Standardized Reporting of Radionuclide Myocardial Perfusion and Function

(2009) Peter L. Tilkemeier et al.   JOURNAL OF NUCLEAR CARDIOLOGY